These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7583392)

  • 1. Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology Group.
    Imbach P; Fuchs A; Berchtold W; Arnet B; Stupnicki A; Angst R; Signer E
    J Pediatr Hematol Oncol; 1995 Nov; 17(4):346-9. PubMed ID: 7583392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in prognosis for children with acute lymphoblastic leukemia.
    Pui CH; Boyett JM; Relling MV; Harrison PL; Rivera GK; Behm FG; Sandlund JT; Ribeiro RC; Rubnitz JE; Gajjar A; Evans WE
    J Clin Oncol; 1999 Mar; 17(3):818-24. PubMed ID: 10071272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. The Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).
    Aricò M; Basso G; Mandelli F; Rizzari C; Colella R; Barisone E; Zanesco L; Rondelli R; Pession A; Masera G
    Cancer; 1995 Apr; 75(7):1684-93. PubMed ID: 8826928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
    Uckun FM; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
    Leuk Lymphoma; 1997 Nov; 27(5-6):445-57. PubMed ID: 9477126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and long-term prognostic value of CD34 in childhood and adult acute lymphoblastic leukemia.
    Vanhaeke DR; Béné MC; Garand R; Faure GC
    Leuk Lymphoma; 1995 Dec; 20(1-2):137-42. PubMed ID: 8750635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of sex in childhood B-precursor acute lymphoblastic leukemia: a Pediatric Oncology Group Study.
    Shuster JJ; Wacker P; Pullen J; Humbert J; Land VJ; Mahoney DH; Lauer S; Look AT; Borowitz MJ; Carroll AJ; Camitta B
    J Clin Oncol; 1998 Aug; 16(8):2854-63. PubMed ID: 9704739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and treatment outcome of children with myeloid antigen coexpression in B-lineage acute lymphoblastic leukemia: a study of 151 Malaysian children.
    Ng SM; Ariffin WA; Lin HP; Chan LL; Chin YM
    J Trop Pediatr; 2000 Apr; 46(2):73-8. PubMed ID: 10822932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
    Uckun FM; Gaynon PS; Sensel MG; Nachman J; Trigg ME; Steinherz PG; Hutchinson R; Bostrom BC; Sather HN; Reaman GH
    J Clin Oncol; 1997 Jun; 15(6):2214-21. PubMed ID: 9196133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-triploidy and near-tetraploidy in childhood acute lymphoblastic leukemia: association with B-lineage blast cells carrying the ETV6-RUNX1 fusion, T-lineage immunophenotype, and favorable outcome.
    Raimondi SC; Zhou Y; Shurtleff SA; Rubnitz JE; Pui CH; Behm FG
    Cancer Genet Cytogenet; 2006 Aug; 169(1):50-7. PubMed ID: 16875937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL; Zhao WL; Nie SS; Guo DD; Ji ZH; Chai YH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1496-500. PubMed ID: 22169311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome and prognostic factors of acute lymphoblastic leukemia in children at the National Cancer Institute, Egypt.
    Hussein H; Sidhom I; Naga SA; Amin M; Ebied E; Khairy A; Kamel A; El-Sharkawy N
    J Pediatr Hematol Oncol; 2004 Aug; 26(8):507-14. PubMed ID: 15284589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
    Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
    J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of commonly used prognostic factors differs for children with T cell acute lymphocytic leukemia (ALL), as compared to those with B-precursor ALL. A Pediatric Oncology Group (POG) study.
    Pullen J; Shuster JJ; Link M; Borowitz M; Amylon M; Carroll AJ; Land V; Look AT; McIntyre B; Camitta B
    Leukemia; 1999 Nov; 13(11):1696-707. PubMed ID: 10557041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
    Boissel N; Auclerc MF; Lhéritier V; Perel Y; Thomas X; Leblanc T; Rousselot P; Cayuela JM; Gabert J; Fegueux N; Piguet C; Huguet-Rigal F; Berthou C; Boiron JM; Pautas C; Michel G; Fière D; Leverger G; Dombret H; Baruchel A
    J Clin Oncol; 2003 Mar; 21(5):774-80. PubMed ID: 12610173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.
    Uckun FM; Aeppli D; Song CW
    Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):899-906. PubMed ID: 8244821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphoblastic lymphoma.
    Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
    Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.